Atopic Dermatitis Treatment Market
Atopic Dermatitis Treatment Market: Key Players to Embrace R&D Activities for Novel Medications: Global Industry Analysis, 2014 - 2018 and Opportunity Assessment, 2019 - 2029
- 2019-10-14
- REP-GB-3097
- 33 Tables
- 94 Figures
- 191 pages
-
An Incisive, In-depth Analysis on the Atopic Dermatitis Treatment Market
This study offers a comprehensive, 360 degree analysis on the Atopic Dermatitis Treatment market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Atopic Dermatitis Treatment market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
COVID -19 : Impact Analysis
Request the coronavirus impact analysis across industries and markets
Request Covid -19 ImpactAtopic Dermatitis Treatment Market - Key Research Findings
- The global atopic dermatitis treatment market in 2018 was valued ~US$ 7.7 Bn.
- The atopic dermatitis treatment market is expected to grow at a CAGR of ~12% during the forecast period of 2019-2029.
- Increasing prevalence of atopic dermatitis and complex interplay between climate change and rising pollution have been driving factors for the atopic dermatitis treatment market growth.
- Collectively, Western Europe and North America, are expected to account for half of the revenue shares in the atopic dermatitis treatment market by the end of 2029.
- North America will continue to be a prominent regional market for atopic dermatitis treatment, due to the increasing prevalence of atopic dermatitis and increased emphasis by manufacturers on partnership with other companies for products in advanced stages of development to enable quicker marketing approval from regulatory bodies.
- Corticosteroids remain the most preferred drug class in the global atopic dermatitis treatment market. Corticosteroids are being used as the first choice of treatment by dermatologist, as it has better anti-inflammatory action and fast onset of action. Biologic therapy is expected to garner significant traction over the forecast period.
- Increase in the number of approval and launch of biologic agents for the treatment of skin diseases, account for the rise in atopic dermatitis treatment market.
- In terms of mode of administration, topical antibiotic pharmaceuticals will continue to be a prominent mode of administration of the atopic dermatitis treatment. Topical medication has been used for the skin diseases over oral, due to its local action resulting in faster recovery from skin diseases.
- In terms of distribution channel, the hospital pharmacies will remain a prominent and largest distribution channel over the forecast period.
Key Factors Shaping the Atopic Dermatitis Treatment Market
- Launch of Topical Non-corticosteroid Immunomodulation for Atopic Dermatitis Treatment
Corticosteroids remain highly preferred drugs for inflammatory diseases like atopic dermatitis treatment, as they act effectively in short duration. However, the long-term use of corticosteroids is associated with skin atrophy and other complications. One of the key factors shaping the atopic dermatitis treatment market is the launch of two topical non-corticosteroid immunomodulators – Tacrolimus and Pimecrolimus – which have promising results in long term, when used in monotherapy compared with combination with corticosteroids.
- Targeted Biologic Therapeutics in Atopic Dermatitis Treatment
Dupilumab is a monoclonal antibody, developing as the first line therapeutic for moderate to serious atopic dermatitis. Dupilumab received approval from the US Food and Drug Administration (FDA) in 2017 for adults with moderate-to-extreme atopic dermatitis which cannot be sufficiently controlled by topical treatment. In 2019, this indication was extended to include adolescent 12 years or older. It is a subcutaneous infusion administered at regular every 2 weeks intervals.
- Industry Consolidations Lead to Faster Time-to-Market
Key players of the atopic dermatitis treatment market are primarily focused on joint venture and partnership with other local players for the development of novel products. The parent organization can use the latter’s clinical improvement expertise and regulatory knowledge to ensure a success circumstance in such associations. Numerous organizations are focusing on expanding their product portfolio by procuring products from the acquired company.
- High Growth Prospects in Developing Economies
Increase investments in the healthcare domain, developing healthcare infrastructure, and increasing prevalence of atopic dermatitis in Asia Pacific region are factors offering a strong impetus to the growth of atopic dermatitis treatment market. The launch of better therapeutic drugs prominently accounts for the growing popularity of atopic dermatitis treatment across developing regional markets. Consistent rise in the number of manufacturers and distributors in the region is likely to contribute to the growth of the atopic dermatitis treatment market in the near future.
Atopic Dermatitis Treatment Competition Analysis
- Key players continue to increase the market share with the launch of new products in the market.
- Joint ventures and partnership with distributors are the strategic actions practised by majority of key players.
- Prominent players continue to address the unmet needs in the market through inorganic strategies, such as mergers and acquisitions.
- The atopic dermatitis treatment market has been relatively moderate in size and likely to remain dynamic, growing in steady pace throughout the forecast period.
- Major players focus on inorganic growth strategy to make a strong hold on targeted in-licensing and acquisitions through expanding its R&D activities and its distribution channels particularly including its specialist retail chains.
Atopic Dermatitis Treatment Market Analysis 2019-2029
A recent market study published by Future Market Insights (FMI) on the atopic dermatitis treatment includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the atopic dermatitis treatment, the growth prospects of the market are obtained with maximum precision.
Atopic Dermatitis Treatment: Segmentation
The global atopic dermatitis treatment is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
|
Drug Class |
Mode of Administration |
Distribution Channel |
Region |
|
|
|
|
Report Chapters
Chapter 01 – Executive Summary
The report initiates with the executive summary of the atopic dermatitis treatment, which includes a summary of key findings and statistics of the market. It also includes demand & supply-side trends pertaining to the atopic dermatitis treatment.
Chapter 02 – Market Overview
Readers can find the definition and a detailed segmentation of the atopic dermatitis treatment in this chapter, which will help them understand the basic information about the atopic dermatitis treatment.
Chapter 03 – Market Background
This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the atopic dermatitis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
Chapter 04 – Market Context
This section includes the premium insights such as regulatory scenario, disease epidemiology and parent market analysis. This section helps readers understand the key factors associated with the atopic dermatitis treatment market.
Chapter 05 – Global Atopic Dermatitis Treatment Demand Analysis 2014-2018 & Opportunity Assessment 2019-2029
This section explains the global market value analysis and forecast for the atopic dermatitis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical atopic dermatitis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).
Chapter 06 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Drug Class
Based on drug type, the atopic dermatitis treatment market is segmented into corticosteroids, calcineurin inhibitors, immunosuppressants, biologic therapy, PDE4 inhibitor, antibiotics, antihistamines, emollients. In this chapter, readers can find information about the key trends and developments in the atopic dermatitis treatment and market attractiveness analysis based on drug type.
Chapter 07 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Mode of Administration
This chapter provides details about the atopic dermatitis treatment based on mode of administration, and has been classified into oral, topical and injectable. In this chapter, readers can understand the market attractiveness analysis based on mode of administration.
Chapter 08 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel
This chapter provides details about the atopic dermatitis treatment market based on distribution channel, and has been classified into hospital pharmacies, retail pharmacies, online pharmacies, drug stores, mail order pharmacies, dermatological clinics. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.
Chapter 09 – Global Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region
This chapter explains how the atopic dermatitis treatment market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA).
Chapter 10 – North America Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter includes a detailed analysis of the growth of the North America atopic dermatitis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.
Chapter 11 – Latin America Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides the growth scenario of atopic dermatitis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
Chapter 12 – Western Europe Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
Important growth prospects of the atopic dermatitis treatment market based on its end users in several countries such as Germany, the U.K., France, Spain, Italy, Russia, BENELUX, and the Rest of Europe are included in this chapter.
Chapter 13 – Eastern Europe Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
In this chapter, Russia, Poland & Rest of Eastern Europe countries are the prominent countries in the Eastern Europe region that are the prime subjects of assessment to obtain the growth prospects of the Eastern Europe atopic dermatitis treatment market. Readers can find detailed information about the growth parameters of the Eastern Europe atopic dermatitis treatment market during the forecast period of 2019-2029.
Chapter 14 – Asia pacific excluding Japan Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter highlights the growth of the atopic dermatitis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the atopic dermatitis treatment market in the APEJ region.
Chapter 15 – Japan Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter highlights the growth of the atopic dermatitis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the atopic dermatitis treatment market in Japan.
Chapter 16 – MEA Atopic Dermatitis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029
This chapter provides information about how the atopic dermatitis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, Turkey, Northern Africa and the Rest of MEA, during the forecast period of 2019-2029.
Chapter 17 – Competition Analysis
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the atopic dermatitis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Novartis, Bayer, Allergan, Sanofi and among others.
Chapter 18 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the atopic dermatitis treatment report.
Chapter 19 – Research Methodology
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the atopic dermatitis treatment.
Sources and Primary Research Splits (%)
Industry Interactions
- C - Level Executives
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Sales Executives
- Industry Experts
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Strategic Growth Initiatives
- Near-term and long-Term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
References Catalogue
- Journals
- American Academy of Dermatology Association (AAD)
- Factiva
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
Get in touch
Harish Tiwari
Global Head - Business Development
Akshay Godge
Client Partner - Global Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.